Does OBINUTUZUMAB Cause Urinary tract infection? 169 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 169 reports of Urinary tract infection have been filed in association with OBINUTUZUMAB (Gazyva). This represents 1.2% of all adverse event reports for OBINUTUZUMAB.
169
Reports of Urinary tract infection with OBINUTUZUMAB
1.2%
of all OBINUTUZUMAB reports
32
Deaths
106
Hospitalizations
How Dangerous Is Urinary tract infection From OBINUTUZUMAB?
Of the 169 reports, 32 (18.9%) resulted in death, 106 (62.7%) required hospitalization, and 9 (5.3%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
Yes, Urinary tract infection is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which OBINUTUZUMAB Alternatives Have Lower Urinary tract infection Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE